Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Plant Biol ; 24(1): 779, 2024 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-39148013

RESUMO

BACKGROUND: ß-Aminobutyric acid (BABA) has been successfully used to prime stress resistance in numerous plant species; however, its effectiveness in forest trees has been poorly explored thus far. This study aimed to investigate the influence of BABA on morphological, physiological, and epigenetic parameters in field elms under various growth conditions. Epigenetic changes were assessed in both DNA and RNA through the use of reversed-phase ultra-performance liquid chromatography (UPLC) coupled with sensitive mass spectrometry. RESULTS: The presented results confirm the influence of BABA on the development, physiology, and stress tolerance in field elms. However, the most important findings are related to the broad epigenetic changes promoted by this amino acid, which involve both DNA and RNA. Our findings confirm, for the first time, that BABA influences not only well-known epigenetic markers in plants, such as 5-methylcytosine, but also several other non-canonical nucleobases, such as 5-hydroxymethyluracil, 5-formylcytosine, 5-hydroxymethylcytosine, N6-methyladenine, uracil (in DNA) and thymine (in RNA). The significant effect on the levels of N6-methyladenine, the main bacterial epigenetic marker, is particularly noteworthy. In this case, the question arises as to whether this effect is due to epigenetic changes in the microbiome, the plant genome, or both. CONCLUSIONS: The plant phenotype is the result of complex interactions between the plant's DNA, the microbiome, and the environment. We propose that different types of epigenetic changes in the plant and microbiome may play important roles in the largely unknown memory process that enables plants to adapt faster to changing environmental conditions.


Assuntos
Epigênese Genética , RNA de Plantas , RNA de Plantas/genética , Estresse Fisiológico/genética , Aminobutiratos/farmacologia , DNA de Plantas/genética
2.
Epilepsia ; 64(3): 769-776, 2023 03.
Artigo em Inglês | MEDLINE | ID: mdl-36520011

RESUMO

OBJECTIVE: Discrimination against persons with epilepsy (PWEs) may persist. The aim of this study was to examine whether epilepsy is an obstacle to desired friendship. METHODS: A factorial survey (vignettes), which is less biased by social desirability, was applied to PWEs, their relatives, and lay persons. The vignettes described a person who was varied by the dimensions of age (younger, same age, older), gender (male, female), disease (healthy, mild epilepsy, severe epilepsy [generalized tonic-clonic seizures], diabetes), origin (German, non-German), contact (phone/internet, activities at home, activities outside), frequency of contacts (weekly, monthly), and distance (around the corner, 10 km away). Respondents rated their willingness to befriend the person on a 10-point Likert scale. Multivariate regression determined the contribution of each dimension on the judgment. RESULTS: Participants were 64 PWEs (age = 37.1 ± 14.0 years), 64 relatives of PWEs (age = 45.1 ± 13.6 years), and 98 controls without contact with PWEs (age = 24.4 ± 10.1 years). Controls were less interested in a friendship with a PWE with mild epilepsy (-3.4%) and even more avoided PWEs with severe epilepsy (-11.7%), whereas in PWEs with tonic-clonic seizures, a mild form of epilepsy was actually conducive to friendship (+7.0%). Controls preferred females (+5.0%) and disliked younger people (-12.3%) and contacts via the internet or telephone (-7.3%). PWEs were also less interested in younger people (-5.8%), and relatives of PWEs had a lower preference for friendships with longer distance (-2.3%). SIGNIFICANCE: PWEs still suffer from a risk of social avoidance, and this becomes more evident with generalized motor seizures.


Assuntos
Epilepsia , Amigos , Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Adolescente , Inquéritos e Questionários , Convulsões , Comportamento Social
3.
Epilepsia ; 63(10): 2694-2702, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-35892320

RESUMO

OBJECTIVE: Because resources are limited in modern health care systems, the decision on the allocation of expensive drugs can be supported by a public consent. This study examines how various factors influence subjectively perceived "fair" pricing of antiseizure medication (ASM) among four groups including physicians, persons with epilepsy (PWEs), their relatives, and a control group. METHODS: We conducted a factorial survey. Vignettes featured a fictional PWE receiving a fictional ASM. The characteristics of the fictional PWE, ASM, and epilepsy varied. Participants were asked to assess the subjectively appropriate annual cost of ASM treatment per year for each scenario. RESULTS: Fifty-seven PWEs (mean age (SD) 37.7 ± 12.3, 45.6% female), 44 relatives (age 48.4 ± 15.7, 51.1% female), 46 neurologists (age 37.1 ± 9.6, 65.2% female), and 47 persons in the control group (age 31.2 ± 11.2, 68.1% female) completed the questionnaire. The amount of money that respondents were willing to spend for ASM treatment was higher than currently needed in Germany and increased with disease severity among all groups. All groups except for PWEs accepted higher costs of a drug with better seizure control. Physicians and the control group, but not PWEs and their relatives, tended to do so also for minor or no side effects. Physicians reduced the costs for unemployed patients and the control group spent less money for older patients. SIGNIFICANCE: ASM effectiveness appears to justify higher costs. However, the control group attributed less money to older PWEs and physicians allocated fewer drug costs to unemployed PWEs.


Assuntos
Epilepsia , Neurologistas , Grupos Controle , Epilepsia/tratamento farmacológico , Feminino , Humanos , Masculino , Convulsões , Inquéritos e Questionários
4.
BMC Neurol ; 20(1): 390, 2020 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-33099323

RESUMO

BACKGROUND: Valproate (VPA) is a commonly prescribed antiepileptic drug for patients experiencing epileptic seizures due to brain tumors. VPA increases radiation sensitivity in various tumor cells in vitro due to complex mechanisms. This could make tumors more vulnerable to ionizing radiation or overcome radioresistance. Yet, clinical data on possible improvement of tumor control by adding VPA to tumor therapy is controversial. Potentially radiosensitizing effects of VPA on healthy tissue remain unclear. To determine individual radiosensitivity, we analyzed blood samples of individuals taking VPA. METHODS: Ex vivo irradiated blood samples of 31 adult individuals with epilepsy were studied using 3-color fluorescence in situ hybridization. Aberrations in chromosomes 1, 2 and 4 were analyzed. Radiosensitivity was determined by the mean breaks per metaphase (B/M) and compared to age-matched (2:1) healthy donors. RESULTS: The patient cohort (n = 31; female: 38.7%) showed an increase of their average B/M value compared to healthy individuals (n = 61; female: 56.9%; B/M: 0.480 ± 0.09 vs. 0.415 ± 0.07; p = .001). The portion of radiosensitive (B/M >  0.500) and distinctly radiosensitive individuals (B/M >  0.600) was increased in the VPA group (54.9% vs. 11.3 and 9.7% vs. 0.0%; p < .001). In 3/31 patients, radiosensitivity was determined prior to and after VPA treatment and radiosensitivity was increased by VPA-treatment. CONCLUSIONS: In our study, we confirmed that patients treated with VPA had an increased radiosensitivity compared to the control group. This could be considered in patients taking VPA prior to the beginning of radiotherapy to avoid toxic side effects of VPA-treatment.


Assuntos
Anticonvulsivantes/farmacologia , Linfócitos/efeitos dos fármacos , Linfócitos/efeitos da radiação , Tolerância a Radiação , Radiossensibilizantes/farmacologia , Ácido Valproico/farmacologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Células Cultivadas , Estudos de Coortes , Epilepsia/tratamento farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem
5.
Ann Neurol ; 84(6): 918-925, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30298621

RESUMO

OBJECTIVE: Despite bioequivalence, the exchangeability of antiepileptic drugs in clinical settings is disputed. Therefore, we investigated the risk for recurrent seizures after switching the manufacturer of the same drug in a large German cohort. METHODS: Anonymous patient data from practice neurologists throughout Germany between 2011 and 2016 were collected using the IMS Disease Analyzer database (QuintilesIMS, Frankfurt, Germany). People with epilepsy were included if at least 2 prescriptions within 360 days and 1 within 180 days prior to the index date were available. The cohort was separated into a seizure group and seizure-free controls. Both groups were matched 1:1 according to age, gender, insurance status, and treating physician. The risk for breakthrough seizures after a manufacturer switch of the same antiepileptic drug was analyzed using multivariate regression models. RESULTS: A total of 3,530 people with epilepsy were included (each group, n = 1,765; age = 53.7 ± 19.8 years). Patients with seizures had switched the drug manufacturer more often than controls (26.8% vs 14.2%; odds ratio [OR] = 1.35, 95% confidence interval [CI] = 1.08-1.69, p = 0.009), both from branded to generic (5.5% vs 2.4%; OR = 1.85, 95% CI = 1.30-2.64, p < 0.001) and between generic drugs (14.7% vs 7.1%; OR = 1.45, 95% CI = 1.13-1.87, p = 0.004). INTERPRETATION: In previously seizure-free patients, switching the manufacturer of antiepileptic medications was associated with a higher risk for seizure recurrence. Our retrospective approach does not allow us to determine whether other changes in medical care at the same time could contribute to the recurrence. However, it would be prudent to avoid switching the manufacturer of anticonvulsants in seizure-free patients. Ann Neurol 2018;84:918-925.


Assuntos
Anticonvulsivantes/uso terapêutico , Substituição de Medicamentos , Epilepsia/tratamento farmacológico , Epilepsia/epidemiologia , Adulto , Fatores Etários , Idoso , Estudos de Coortes , Medicamentos Genéricos/uso terapêutico , Feminino , Alemanha/epidemiologia , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Medicamentos sob Prescrição/uso terapêutico , Adulto Jovem
6.
Epilepsy Behav ; 81: 94-100, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29454606

RESUMO

OBJECTIVE: Only limited data exist on psychosocial long-term outcome after epilepsy surgery in patients with extratemporal epilepsy. The aim of this study was to investigate psychosocial outcome after extratemporal epilepsy surgery and to assess factors predicting favorable outcome. METHOD: Sixty-five out of 104 eligible patients who had undergone extratemporal epilepsy surgery at our epilepsy center between 1990 and 2015 (mean age: 42.2. years; 75% of the resections in the frontal lobe) completed a questionnaire asking about seizure status, employment status, marital and living situation, driving status, depressive symptoms, and quality of life (QOL). Follow-up was on average 9.2years after surgery (range: 1-26years). RESULTS: Thirty-eight (58%) patients were free of disabling seizures (Engel class I), and 28 (43%) have not experienced any seizures after surgery (Engel class IA). Employment rate in the primary labor market remained at 45%, but more patients lost employment (14%) than gained employment (8%). Postoperative employment was predicted by preoperative employment (p=.007), seizure freedom (p=.025), older age at seizure onset (p=.018), younger age at follow-up (p=.035), and female gender (p=.048). Seizure-free patients were more likely to be driving; have a partner, particularly in males; and have lower depressive scores. Quality of life at follow-up was best predicted by employment (p=.012), partnership (p=.025), and seizure freedom (p=.025). In contrast, recurrence of seizures and early seizure onset were associated with poor psychosocial outcome, particularly in men. CONCLUSION: The study provides support that extratemporal surgery can lead to improved QOL and favorable psychosocial outcome. Seizure freedom is important but not the only determinant of good psychosocial outcome.


Assuntos
Epilepsia/psicologia , Convulsões/psicologia , Adolescente , Adulto , Condução de Veículo/estatística & dados numéricos , Depressão/epidemiologia , Emprego/estatística & dados numéricos , Epilepsia/cirurgia , Feminino , Seguimentos , Lobo Frontal/cirurgia , Humanos , Masculino , Estado Civil , Pessoa de Meia-Idade , Qualidade de Vida , Recidiva , Análise de Regressão , Adulto Jovem
7.
Epilepsia ; 55(12): 2003-16, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25366369

RESUMO

OBJECTIVE: Hippocampal sclerosis (HS) is the major structural brain lesion in patients with temporal lobe epilepsy (TLE). However, its internal anatomic structure remains difficult to recognize at 1.5 or 3 Tesla (T) magnetic resonance imaging (MRI), which allows neither identification of specific pathology patterns nor their proposed value to predict postsurgical outcome, cognitive impairment, or underlying etiologies. We aimed to identify specific HS subtypes in resected surgical TLE samples on 7T MRI by juxtaposition with corresponding histologic sections. METHODS: Fifteen nonsclerotic and 18 sclerotic hippocampi were studied ex vivo using an experimental 7T MRI scanner. T2 -weighted images (T2wi) and diffusion tensor imaging (DTI) data were acquired and validated using a systematic histologic analysis of same specimens along the anterior-posterior axis of the hippocampus. RESULTS: In nonsclerotic hippocampi, differences in MR intensity could be assigned to seven clearly recognizable layers and anatomic boundaries as confirmed by histology. All hippocampal subfields could be visualized also in the hippocampal head with three-dimensional imaging and angulated coronal planes. Only four discernible layers were identified in specimens with histopathologically confirmed HS. All sclerotic hippocampi showed a significant atrophy and increased signal intensity along the pyramidal cell layer. Changes in DTI parameters such as an increased mean diffusivity, allowed to distinguish International League Against Epilepsy (ILAE) HS type 1 from type 2. Whereas the increase in T2wi signal intensities could not be attributed to a distinct specific histopathologic substrate, that is, decreased neuronal or increased glial cell densities, intrahippocampal projections and fiber tracts were distorted in HS specimens suggesting a complex disorganization of the cellular composition, fiber networks, as well as its extracellular matrix. SIGNIFICANCE: Our data further advocate high-resolution MRI as a helpful and promising diagnostic tool for the investigation of hippocampal pathology along the anterior-posterior extent in TLE, as well as in other neurologic and neurodegenerative disorders.


Assuntos
Imagem de Tensor de Difusão , Epilepsia do Lobo Temporal/patologia , Hipocampo/patologia , Processamento de Imagem Assistida por Computador , Epilepsia do Lobo Temporal/complicações , Feminino , Proteína Glial Fibrilar Ácida/metabolismo , Hipocampo/metabolismo , Humanos , Cooperação Internacional , Masculino , Proteína Básica da Mielina/metabolismo , Fibras Nervosas Mielinizadas/metabolismo , Fibras Nervosas Mielinizadas/patologia , Neuroglia/metabolismo , Neuroglia/patologia , Neurônios/metabolismo , Neurônios/patologia , Fosfopiruvato Hidratase/metabolismo , Esclerose/etiologia , Estatísticas não Paramétricas
8.
Epilepsia ; 53(7): e115-8, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22554199

RESUMO

To elucidate, in a pilot-study, whether noninvasive transcutaneous vagus nerve stimulation (t-VNS) is a safe and tolerable alternative treatment option in pharmacoresistant epilepsy. t-VNS was applied to 10 patients with pharmacoresistant epilepsies. Stimulation via the auricular branch of the vagus nerve of the left tragus was delivered three times per day for 9 months. Subjective documentation of stimulation effects was obtained from patients' seizure diaries. For a more reliable assessment of seizure frequency, we carried out prolonged outpatient video-electroencephalography (EEG) monitoring. In addition, computerized testing of cognitive, affective, and emotional functions was performed. Three patients aborted the study. Of the remaining seven patients, an overall reduction of seizure frequency was observed in five patients after 9 months of t-VNS. The noninvasive t-VNS stimulation is a safe and well-tolerated method for relatively long periods, and might be an alternative treatment option for patients with epilepsy.


Assuntos
Epilepsia/terapia , Pele/inervação , Estimulação do Nervo Vago/métodos , Adolescente , Adulto , Antieméticos/efeitos adversos , Cognição/fisiologia , Orelha/inervação , Eletroencefalografia , Emoções , Epilepsia/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Escalas de Graduação Psiquiátrica , Gravação em Vídeo , Adulto Jovem
9.
Epilepsia ; 52(1): 35-44, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20946127

RESUMO

PURPOSE: Long-term epilepsy associated tumors (LEATs) are a frequent cause of drug-resistant partial epilepsy. A reliable tumor diagnosis has an important impact on therapeutic strategies and prognosis in patients with epilepsy, but often is difficult by magnetic resonance imaging (MRI) only. Herein we analyzed a large LEAT cohort investigated by 18fluoroethyl-L-tyrosine-positron emission tomography (FET-PET). METHODS: Thirty-six patients with chronic partial epilepsy and a LEAT-suspect MRI lesion were analyzed by FET-PET using visual inspection and quantitative analysis of standard uptake values (SUV). PET results were correlated with clinical and histopathologic data. RESULTS: FET-PET study was positive in 22 of 36 analyzed lesions and in 14 of 22 histologically verified LEAT lesions. The precise World Health Organization (WHO) tumoral entity was not predicted by FET-PET. Notably, FET uptake correlated strikingly with age at epilepsy onset (p = 0.001). Further correlations were seen for age at surgery (p = 0.007) and gadolinium-contrast enhancement on MRI (p < 0.05). DISCUSSION: FET-PET is a helpful tool for LEAT diagnosis, particularly when MRI readings are ambiguous. FET uptake, which is likely mediated by the l-amino acid transporter (LAT) family, might indicate a principally important biologic property of certain LEATs, since LAT molecules also are involved in cell growth regulation.


Assuntos
Neoplasias Encefálicas/diagnóstico por imagem , Epilepsia/diagnóstico por imagem , Radioisótopos de Flúor , Glioma/diagnóstico por imagem , Tomografia por Emissão de Pósitrons , Tirosina , Adolescente , Adulto , Neoplasias Encefálicas/complicações , Criança , Estudos de Coortes , Epilepsia/etiologia , Feminino , Glioma/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia por Emissão de Pósitrons/métodos , Fatores de Tempo , Adulto Jovem
10.
Seizure ; 57: 56-62, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29604610

RESUMO

PURPOSE: The incidence of epilepsy in older adults is growing, as does the incidence of comorbidities. Therefore, when it comes to epilepsy surgery in medically intractable epilepsy, age is often seen as a limiting factor. To investigate the outcome after epilepsy surgery in a population of older adults, we compared the benefit for patients aged 50-59 years with those aged 60 years and older in respect of efficacy and safety. METHOD: Patients aged ≥50 years with medically intractable epilepsy who underwent epilepsy surgery from 1990 to 2013 were selected from the database of a German epilepsy center. All of them received a standardised and detailed presurgical diagnostic evaluation. Follow-up included at least four scheduled visits with EEG, MRI and neuropsychological testing. Outcome was assessed using the Engel outcome scale. RESULTS: 79 patients aged between 50 and 67 years were followed-up for a median of 4.7 years (2-16 years). 68% of patients were free of disabling seizures (Engel class I, ≥60 years: 75%) and 58% were seizure-free (Engel class IA, ≥60 years: 70%). 90% of our patients suffered from temporal lobe epilepsy (TLE), 9% from frontal lobe epilepsy (FLE) and one occipital lobe epilepsy (OLE). After surgery, 9% discontinued or tapered their medication. Permanent surgical complications occurred in 10% of cases and transient neurological deficits were seen in 11%. Older patients had a higher risk for postoperative hygroma (≥60 years 15%; <60 years 8%) and were more prone to postoperative memory deficits (≥60 years 45%), especially after resection of the dominant temporal lobe. Verbal and figural memory testing did not differ significantly between the groups. CONCLUSIONS: The results support the view that in selected older patients, epilepsy surgery shows equal or even higher success rates as compared to younger patients. However, patients of older age may be at greater risk for postoperative hygroma and memory deficits, especially after dominant temporal lobe resections.


Assuntos
Epilepsia Resistente a Medicamentos/cirurgia , Fatores Etários , Idoso , Encéfalo/diagnóstico por imagem , Encéfalo/fisiopatologia , Encéfalo/cirurgia , Epilepsia Resistente a Medicamentos/diagnóstico por imagem , Epilepsia Resistente a Medicamentos/fisiopatologia , Epilepsia Resistente a Medicamentos/psicologia , Eletroencefalografia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Fisiológica , Testes Neuropsicológicos , Complicações Pós-Operatórias , Estudos Retrospectivos , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento
11.
Neuroimage Clin ; 19: 487-496, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29984157

RESUMO

Background: Epilepsy surgery for focal cortical dysplasia type II (FCD II) offers good chances for seizure freedom, but remains a challenge with respect to lesion detection, defining the epileptogenic zone and the optimal resection strategy. Integrating results from magnetic source imaging from magnetoencephalography (MEG) with magnetic resonance imaging (MRI) including MRI postprocessing may be useful for optimizing these goals. Methods: We here present data from 21 adult FCD II patients, investigated during a 10 year period and evaluated including magnetic source imaging. 16 patients had epilepsy surgery, i.e. histopathologically verified FCD II, and a long follow up. We present our analysis of epileptogenic zones including MEG in relation to structural data according to MRI data and relate these results to surgical outcomes. Results: FCD II in our cohort was characterized by high MEG yield and localization accuracy and MEG showed impact on surgical success-rates. MEG source localizations were detected in 95.2% of patients and were as close as 12.3 ±â€¯8,1 mm to the MRI-lesion. After a mean follow up of >3 years, we saw >80% Engel I outcomes, with more favourable outcomes when the MEG source was completely resected (Fishers exact test 0,033). Conclusion: We argue for a high value of conducting a combined MEG-MRI approach in the presurgical workup and the resection strategy in patients with FCD II related epilepsy.


Assuntos
Epilepsia/cirurgia , Imageamento por Ressonância Magnética , Malformações do Desenvolvimento Cortical do Grupo I/cirurgia , Malformações do Desenvolvimento Cortical/cirurgia , Adolescente , Adulto , Criança , Estudos de Coortes , Eletroencefalografia/métodos , Epilepsia/patologia , Feminino , Humanos , Imageamento por Ressonância Magnética/métodos , Magnetoencefalografia/métodos , Masculino , Malformações do Desenvolvimento Cortical/patologia , Malformações do Desenvolvimento Cortical do Grupo I/patologia , Estudos Retrospectivos , Adulto Jovem
12.
Neurology ; 87(5): 466-72, 2016 Aug 02.
Artigo em Inglês | MEDLINE | ID: mdl-27371490

RESUMO

OBJECTIVE: To assess the effect of patient and drug characteristics on medication adherence in people with epilepsy (PWE) in a large cohort representative of the German population. METHODS: Information was obtained from the Disease Analyzer database that collects anonymous demographic and medical data from practice computer systems throughout Germany. From 2010 to 2013, adult PWE were retrospectively analyzed regarding demographic characteristics, comorbidities, and treatment with antiepileptic drugs (AED). Adherence was measured using the medication possession ratio (MPR). Individuals with an MPR <80% were classified as nonadherent. Multivariate regression models were applied to assess the association of different factors with adherence by calculating adjusted odds ratios (OR) with 95% confidence intervals. RESULTS: A total of 31,317 PWE were included. The mean MPR was 81.1% (SD 25.7%) with 64.7% of patients showing good adherence (MPR >80%). Patient-related factors associated with good adherence to AED treatment were West German residence (OR 1.23, p < 0.0001) and learning disability (OR 1.80, p < 0.0001). Adherence was higher in patients treated with new than old (OR 1.52, p < 0.0001) and branded than generic AED (OR 1.44, p < 0.0001). Among the most common AED, levetiracetam achieved best adherence (OR 2.85, p < 0.0001), valproate lowest. Two or more daily dosages reduced adherence (TID vs QD: OR 0.84, p = 0.005; BID vs QD: OR 0.86, p = 0.011). CONCLUSIONS: One third of PWE treated with AED in Germany showed poor adherence, which was related to demographic characteristics and drug properties. Administration of new, well-tolerated drugs in simple dosage regimens improved AED compliance.


Assuntos
Anticonvulsivantes/uso terapêutico , Adesão à Medicação/estatística & dados numéricos , Adulto , Comorbidade , Bases de Dados Factuais , Epilepsia/tratamento farmacológico , Feminino , Alemanha , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto Jovem
13.
J Neuroimmunol ; 168(1-2): 175-82, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16126281

RESUMO

Subcutaneous Interferon-beta (IFN-beta) injections for the treatment of multiple sclerosis (MS) frequently cause inflammatory injection site reactions. To study the role of chemokines we obtained skin biopsies from 7 MS patients 24 h after injection. At the IFN-beta but not at the contralateral placebo injection sites, we observed strong IP-10/CXCL10 and moderate MCP-1/CCL2 expression associated with extensive perivascular, highly CXCR3-positive T cell and macrophage infiltrates. Primary human skin cells displayed a comparable pattern of chemokine induction after stimulation with IFN-beta in vitro. IFN-beta may therefore trigger inflammatory skin reactions through local chemokine induction followed by rapid immune cell extravasation.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Interferon beta/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Pele/efeitos dos fármacos , Antígenos CD/metabolismo , Biópsia , Células Cultivadas , Quimiocinas/genética , Quimiocinas/metabolismo , Citocinas/genética , Citocinas/metabolismo , Citocinas/farmacologia , Relação Dose-Resposta a Droga , Ensaio de Desvio de Mobilidade Eletroforética/métodos , Ensaio de Imunoadsorção Enzimática/métodos , Feminino , Regulação da Expressão Gênica/fisiologia , Humanos , Imuno-Histoquímica/métodos , Hibridização In Situ/métodos , Injeções Subcutâneas/métodos , Masculino , Esclerose Múltipla/patologia , Esclerose Múltipla/fisiopatologia , Pele/patologia
14.
Epilepsy Res ; 110: 62-70, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25616457

RESUMO

PURPOSE: For safe 3T-MRI of patients with VNS (vagus nerve stimulator), specific conditions are mandatory. However, application of these conditions can lead to a loss of image quality. In this work, we evaluated the diagnostic value of 3T-MRI in VNS patients with pharmacoresistant epilepsy. METHODS: Using a transmit-and-receive head coil and adapting our sequences to allow for low SAR (specific absorption rate), we examined 15 patients with pharmacoresistant epilepsy. Diagnostic quality was assessed by comparison of the SNR (signal to noise ratio) and CNR (contrast to noise ratio) of the hippocampus, the grey-white matter contrast and epileptogenic lesions to images of patients without VNS acquired with our routine 3T-MRI protocol and the 32-channel head coil. RESULTS: 3T-MRI is feasible in VNS-patients. Image quality is adequate for detection and follow-up of epileptogenic lesions such as ganglioglioma or PNH (periventricular nodular heterotopia). Due to a significant reduction of SNR and CNR, the diagnostic value for subtle lesions may be decreased. Overall, the feasibility of 3T-MRI is beneficial in the diagnostic workup and follow-up of epilepsy-patients with VNS.


Assuntos
Encéfalo/patologia , Epilepsia/patologia , Epilepsia/terapia , Imageamento por Ressonância Magnética/métodos , Estimulação do Nervo Vago , Adulto , Idoso , Resistência a Medicamentos , Estudos de Viabilidade , Feminino , Substância Cinzenta/patologia , Humanos , Imageamento por Ressonância Magnética/instrumentação , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Razão Sinal-Ruído , Substância Branca/patologia
15.
J Neuroimmunol ; 135(1-2): 161-5, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12576237

RESUMO

T-cell apoptosis in the CNS is an effective mechanism for the noninflammatory resolution of autoimmune T-cell infiltrates. Ingestion of apoptotic leukocytes by microglia results in an efficient clearance of the inflammatory infiltrate, followed by a profound downregulation of proinflammatory phagocyte immune functions. The effects of different immunomodulatory agents on Lewis rat microglial phagocytosis of apoptotic autologous thymocytes or myelin-basic protein (MBP)-specific, encephalitogenic T-cells were investigated using a standardized, light microscopical in vitro phagocytosis assay. Pretreatment of microglia with polyclonal 7S immunoglobulins (IVIg) decreased the phagocytosis of apoptotic thymocytes by 38.2% (p<0.0001). Also, immunoglobulin F(ab')(2) fragments decreased microglial phagocytosis, suggesting an Fc receptor-independent mechanism. Similar results were obtained using MBP-specific T-cells. Pretreatment of microglia with IFN-gamma increased the phagocytosis of apoptotic cells by 65.4%, which was to a large extent counteracted by IVIg. Glatiramer acetate (GLAT) did not exert an effect on microglial phagocytosis, while methylprednisolone (MP) induced microglial apoptosis in vitro. These results indicate that IVIg has a high potential to inhibit microglial phagocytosis of apoptotic inflammatory T-cells even under proinflammatory conditions and extend our view of the complex immunomodulatory effects of IVIg.


Assuntos
Apoptose , Fragmentos Fab das Imunoglobulinas/farmacologia , Imunoglobulinas Intravenosas/farmacologia , Microglia/imunologia , Fagocitose/efeitos dos fármacos , Linfócitos T/fisiologia , Animais , Células Cultivadas , Acetato de Glatiramer , Interferon gama/farmacologia , Metilprednisolona/farmacologia , Peptídeos/farmacologia , Ratos , Ratos Endogâmicos Lew
16.
Clin Neurophysiol ; 125(7): 1346-52, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24462506

RESUMO

OBJECTIVE: In a previous study we proposed a robust method for automatic seizure detection in scalp EEG recordings. The goal of the current study was to validate an improved algorithm in a much larger group of patients in order to show its general applicability in clinical routine. METHODS: For the detection of seizures we developed an algorithm based on Short Time Fourier Transform, calculating the integrated power in the frequency band 2.5-12 Hz for a multi-channel seizure detection montage referenced against the average of Fz-Cz-Pz. For identification of seizures an adaptive thresholding technique was applied. Complete data sets of each patient were used for analyses for a fixed set of parameters. RESULTS: 159 patients (117 temporal-lobe epilepsies (TLE), 35 extra-temporal lobe epilepsies (ETLE), 7 other) were included with a total of 25,278 h of EEG data, 794 seizures were analyzed. The sensitivity was 87.3% and number of false detections per hour (FpH) was 0.22/h. The sensitivity for TLE patients was 89.9% and FpH=0.19/h; for ETLE patients sensitivity was 77.4% and FpH=0.25/h. CONCLUSIONS: The seizure detection algorithm provided high values for sensitivity and selectivity for unselected large EEG data sets without a priori assumptions of seizure patterns. SIGNIFICANCE: The algorithm is a valuable tool for fast and effective screening of long-term scalp EEG recordings.


Assuntos
Algoritmos , Eletroencefalografia/métodos , Eletroencefalografia/normas , Epilepsia/cirurgia , Cuidados Pré-Operatórios/métodos , Convulsões/diagnóstico , Adolescente , Adulto , Idoso , Limiar Diferencial , Epilepsia do Lobo Temporal/diagnóstico , Feminino , Análise de Fourier , Humanos , Masculino , Pessoa de Meia-Idade , Couro Cabeludo , Sensibilidade e Especificidade , Processamento de Sinais Assistido por Computador , Gravação em Vídeo , Adulto Jovem
17.
Seizure ; 22(6): 424-32, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22999215

RESUMO

PURPOSE: Optimized therapy in epilepsy should include individual care for cognitive functions. Here we introduce a computerized screening instrument, called "Computerized Cognitive Testing in Epilepsy" (CCTE), which allows for time-efficient repetitive assessment of the patient's cognitive profile regarding the domains of memory and attention, which are frequently impaired due to side effects of antiepileptic medication. METHODS: The CCTE battery takes 30min and covers tasks of verbal and figural memory, cognitive speed, attention and working memory. The patient's results are displayed immediately in comparison to age-related normative data. For evaluation of psychometrics and clinical correlations, data from patients of a tertiary referral epilepsy center (n=240) and healthy subjects (n=83) were explored. RESULTS: CCTE subtests show good reliability and concurrent validity compared to standard neuropsychological tests (p<0.01). Adverse cognitive effects of antiepileptic medication can be detected (p<0.05), e.g. significant negative effects of increasing drug load. Specific epilepsy subgroups, e.g. focal versus primary generalized epilepsy or right versus left mesial temporal lobe epilepsy, showed different CCTE profiles. CONCLUSION: CCTE appears valuable for early detection of individual cognitive alterations related to medication. In addition, it displays interesting differences between epilepsy syndromes. The CCTE battery provides a standardized, time- and personnel-efficient assessment of cognitive functions open to a large number of patients and applicable for clinical and scientific use in epilepsy.


Assuntos
Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/etiologia , Diagnóstico por Computador/métodos , Epilepsia/complicações , Testes Neuropsicológicos , Adulto , Fatores Etários , Anticonvulsivantes/uso terapêutico , Atenção , Epilepsia/tratamento farmacológico , Análise Fatorial , Feminino , Humanos , Testes de Inteligência , Masculino , Memória , Pessoa de Meia-Idade , Psicometria , Reprodutibilidade dos Testes , Índice de Gravidade de Doença , Adulto Jovem
18.
J Neurol ; 259(11): 2376-84, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22544296

RESUMO

Nationwide analyses of drug use can provide a prevalence estimate of the underlying disease and can help in understanding the characteristics of treatment. This study aimed for such analyses regarding the utilization of antiepileptic drugs (AED) for epilepsy in Germany. In 2009, all 4,115,705 AED prescriptions of all German patients with statutory health insurance (70,011,508 persons) were retrospectively analyzed. The IMS(®) LRx database served as data source, which accesses nationwide pharmacy data centers processing all German prescription data. To establish the age and sex-specific percentage of patients taking AED because of epilepsy, we used a second database, Disease Analyzer(®), which covered a representative sample of the German population (7.2 million patients) and contained ICD10 codes alongside with prescription data. The period prevalence of patients taking AED because of epilepsy was 9.1/1,000 (children/adolescents: 5.2/1,000; elderly: 12.5/1,000). Of the patients, 83.1 % took at least one of four AED: valproate (29.8 %), carbamazepine (26.4 %), lamotrigine (21.4 %), and levetiracetam (16.9 %). Oxcarbazepine and sultiame were popular with pediatricians. Elderly patients frequently received phenytoin and primidone. More than half of the patients were treated by family physicians; 68 % took AED in monotherapy and 7.9 % received >2 AED (children/adolescents: 12.5 %). The costs for AED prescribed for epilepsy amounted to €285.1 Mio (median AED costs/patient: €158/a). The German 2009 prevalence of epileptic patients taking AED was 9.1/1,000. Family physicians cared for the majority of patients. Prevalence and prescribing patterns changed with age. Costs of AED against epilepsy added up to 1 % of total medication costs in Germany.


Assuntos
Anticonvulsivantes/economia , Anticonvulsivantes/uso terapêutico , Epilepsia/tratamento farmacológico , Epilepsia/economia , Vigilância da População/métodos , Adolescente , Adulto , Idoso , Carbamazepina/economia , Carbamazepina/uso terapêutico , Criança , Bases de Dados Factuais , Epilepsia/epidemiologia , Alemanha/epidemiologia , Humanos , Lamotrigina , Levetiracetam , Pessoa de Meia-Idade , Piracetam/análogos & derivados , Piracetam/economia , Piracetam/uso terapêutico , Prevalência , Estudos Retrospectivos , Triazinas/economia , Triazinas/uso terapêutico , Ácido Valproico/economia , Ácido Valproico/uso terapêutico , Adulto Jovem
19.
Comput Methods Biomech Biomed Engin ; 13(3): 431-40, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20013437

RESUMO

In this paper, a numerical procedure to determine an optimal applicator placement for hepatic radiofrequency ablation incorporating uncertain material parameters is presented. The main focus is set on the treatment of subjective and rare data-based information. For this purpose, we employ the theory of fuzzy sets and model uncertain parameters as fuzzy quantities. While fuzzy modelling has been established in structural engineering in the recent past, it is novel in biomedical engineering. Incorporating fuzzy quantities within an optimisation task is basically innovative. In our context, fuzzy modelling allows us to determine an optimal applicator placement that maximises the therapy success under the given uncertainty conditions. The applicability of our method is demonstrated by means of an example case.


Assuntos
Neoplasias Hepáticas/radioterapia , Lógica Fuzzy , Humanos , Radioterapia/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA